India’s total ‘Active Caseload’ has reached 5,21,808 on Monday with present active caseload now standing at 4.33 percent of the country’s total Positive Cases. A net incline of 35,498 cases recorded from the total active caseload in the last 24 hours.
The cumulative recovery rate stands at 1,13,55,993 on Monday morning whereas the national Recovery Rate is 94.32 percent with a total recovery rate of 32,231 cases in the last 24 hours.
Maharashtra has reported the maximum number of single day recoveries with 17,874 newly recovered cases on Monday morning, however, 291 deaths have been reported in the last 24 hours.
During the last 24 hours, 312 deaths were reported in the country. Six States account for 82.69 per cent of the new deaths while Maharashtra has registered the maximum casualties 166. Punjab follows with 45 daily deaths and Kerala reported 14 deaths in the last 24 hours.
Fifteen States and Union Territories (UTs) have not reported any COVID19 deaths in the last 24 hours. These are Assam, Uttarakhand, Odisha, Puducherry, Ladakh (UT), D&D & D&N, Lakshadweep, Manipur, Tripura, Sikkim, Meghalaya, Mizoram, A&N Islands, Nagaland and Arunachal Pradesh.
Union Health Secretary chaired a high-level review meeting on Saturday with Additional Chief Secretaries, Principal Secretaries and Secretaries of Health and Family Welfare of 12 States and Municipal Commissioners and District Collectors of 46 districts that are the most affected by rising cases and rising mortality because of COVID-19.
These States are Maharashtra, Gujarat, Haryana, Tamil Nadu, Chhattisgarh, Madhya Pradesh, West Bengal, Delhi, Jammu and Kashmir, Karnataka, Punjab and Bihar.
On the other hand, the total vaccination coverage in India has crossed six crores.
More than 6.05 cr (6,05,30,435) vaccine doses have been administered through 9,92,483 sessions, as per the provisional report till 7 am on Monday.
These include 81,56,997 HCWs (1st dose), 51,78,065 HCWs (2nd dose), 89,12,113 FLWs (1st dose) and 36,92,136 FLWs (2nd Dose), 67,31,223 beneficiaries aged more than 45 years with specific comorbidities (1st Dose) and 2,78,59,901 beneficiaries aged more than 60 years. (UNI)